Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Sharon R, Bar-Joseph I, Frosch MP, Walsh DM, Hamilton JA, Selkoe DJ. The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron. 2003 Feb 20;37(4):583-95. PubMed Abstract


Corresponding Author: Dennis Selkoe
  
Comments on Paper and Primary News
  Primary News: Playing "Gotcha" with the Phantom: α-synuclein Oligos Spotted in Vivo

Comment by:  Junying Yuan
Submitted 23 February 2003  |  Permalink Posted 23 February 2003

This is a fascinating paper! It reveals a side of α-synuclein—an elusive neuron killer—which has escaped detection until now. This work may open a new chapter in the research of neurodegenerative diseases, namely, examining the role of lipids in preventing and/or promoting neural degeneration. Like all good work, this paper raises more questions than the answers it provides. Burning questions would include, for example, whether the accumulation of soluble oligomers to a certain level is sufficient for neural degeneration, or just a prelude for neural degeneration. If soluble oligomers just set the stage for neural degeneration, then it will be important to find out whether this is because soluble oligomers have to recruit additional factors or have to proceed to the stage of insoluble aggregates in order for neurons to die. We can be sure many interesting papers will follow this work!

View all comments by Junying Yuan

  Primary News: Playing "Gotcha" with the Phantom: α-synuclein Oligos Spotted in Vivo

Comment by:  Dora M. Kovacs, ARF Advisor
Submitted 5 March 2003  |  Permalink Posted 5 March 2003

The obvious conclusion of this important paper is that PUFAs (polyunsaturated fatty acids) induce oligomerization of α-synuclein into neurotoxic species. Another potential source of neurotoxicity caused by PUFA-α-synuclein oligomers is that they may sequester biologically active PUFAs away in the neuron, ultimately resulting in neuronal dysfunction. It should by noted that levels of biologically active PUFAs in neurons are already relatively low even though they are required for a battery of cellular functions, including cell signaling and gene expression. Therefore, the existence of highly soluble α-synuclein oligomers may be doubly toxic, when potential sequestration of biologically active PUFAs is added to the equation.

View all comments by Dora M. Kovacs
  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 

REAGENTS/MATERIAL:

Transgenic mice expressing human wt alphaS under control of growth factor B (provided by Drs. Goldberg and Shen) were used in this study.

Western blotting probed with anti-human alphaS LB509 (Zymed), anti-human alphaS (Q Biogene), mouse and human alphaS H3C, Syn-1 (Transduction Labs and anti-ubiquitin (MBL).

FUTURE DIRECTION:
Now that these oligomers have been detected, the question is are they toxic? Finding the answer will be one research priority.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad